A number one automation firm powering life sciences labs, has raised $40m to speed up its fast progress and business presence throughout the US, UK and EMEA.
Scientific organizations are more and more targeted on the pace and adaptability of their experimentation and knowledge assortment. That is taking place similtaneously they battle to search out laboratory actual property in addition to discovering and retaining expert lab employees. This convergence is resulting in organisations rethinking their tooling, knowledge infrastructure and talent to experiment at scale.
Automata’s LINQ automation platform is designed to make automation simply adoptable by science labs throughout analysis establishments, hospital teams and pharmaceutical and biotech corporations and CROs, whether or not they’re operating excessive throughput workflows or experimenting with a excessive charge of workflow changeover requiring dynamic protocol growth.
Dimension led the spherical with participation from A.P. Moller Holding, mother or father firm of the A.P. Moller Group and house owners of, amongst different companies, laboratory testing group Unilabs. They’ve invested alongside returning buyers, Octopus Ventures, Hummingbird, Isomer Capital, Potential Ventures and Aldea Ventures.
The proceeds might be used to fund Automata’s geographic and staff enlargement plans, focusing the enterprise on the fast-growing alternatives within the world life sciences sector and growing its model recognition and presence within the business.
This newest funding spherical builds on the success of the $50m Sequence B spherical raised in January 2022 which enabled the staff to ship on its preliminary commercialisation and enlargement plans, particularly its deployment footprint in Europe and the UK and fast progress within the US. Because the final funding spherical in January 2022, Automata has seen 150% income progress. It has additionally seen a 12-times enhance in dwell system hours in customer-deployed programs.
Present prospects embrace NHS Trusts reminiscent of The Royal Marsden NHS Basis Belief, educational establishments together with The Francis Crick Institute, testing labs reminiscent of HSL, CDMOs and CROs, pharma and biotech corporations, reminiscent of Astra Zeneca and bit.bio.
“The final two years have been vastly thrilling at Automata as we’ve seen LINQ enhance the dimensions of buyer workflows in addition to meaningfully rising their capacity to generate top quality knowledge – accelerating their tempo of discovery and experimentation.”
Mostafa Elsayed, Founder and CEO of Automat
He added, “Reaching a fundraise with thrilling and skilled buyers in a fairly difficult funding atmosphere is an actual endorsement of the potential and capabilities of our lab automation platform and the work the staff has achieved.”
He additionally added, “The elevate permits us to proceed to concentrate on our current and upcoming deployments in addition to persevering with to develop merchandise that rework how scientists work together with their labs. Most significantly, it can assist us to speed up the affect our customers are already having on individuals’s lives all over the world.”
The elevate permits us to proceed to concentrate on our current and upcoming deployments in addition to persevering with to develop merchandise that rework how scientists work together with their labs. Most significantly, it can assist us to speed up the affect our customers are already having on individuals’s lives all over the world.”
Mostafa Elsayed, Founder and CEO of Automata
“The fashionable lab is an information manufacturing unit, requiring exact coordination throughout a collection of lab devices juggling a number of protocol runs. Consequently, the business wants a lab automation system that’s constructed with an emphasis on pace, reliability, reconfigurability, reproducibility, and scale. Automata’s modular software program and {hardware} LINQ system delivers simply that and we’re thrilled to accomplice with them to construct a category-defining enterprise on this area.”
Nan Li, Co-Founder and Managing Companion of Dimension
“We’re delighted to accomplice with Automata, an rising chief in modernizing and automating the worldwide life science business. Automata’s options assist enhance throughput, decrease value, and speed up innovation permitting its prospects to concentrate on pushing additional into innovative medical and life science analysis.”
Chetan Mehta, Head of Progress Fairness of A.P. Moller Holding
